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Background: Special insoles and shoes designed to prevent foot ulcers caused by repetitive high pres-
sures are recommended for patients with diabetes who have any of the following risk factors: neu-
ropathy; peripheral vascular disease; foot deformities; previous ulcers; amputation; and skin
pathologies. However, there is a need for increased knowledge regarding: a) differences in the peak
pressure (PP) and pressure time integral (PTI) for different types of insoles; and b) the properties of the
pressure distribution for insoles used over a period of several months. We present the results of a
randomized trial to compare the plantar pressures of three commonly used insoles.
Objectives: The primary objective was to compare the PP and PTI between three types of insoles. The
secondary objective was to explore the long-term pattern of peak plantar pressure distribution and
variations in speciﬁc regions of interest (ROI). The tertiary objective was to investigate the impacts of
insole adjustments, how much the insoles were used, and the levels of patient satisfaction.
Methods: In a 2-year trial, 114 patients with type 1 (N ¼ 31) or type 2 (N ¼ 83) diabetes (62 men and 52
women; mean age, 57.7  15.4 years; duration of diabetes, 12.3  11.2 years; neuropathy, 38%), were
randomized to be supplied with one of three different insoles. The ethylene vinyl acetate (EVA) insoles
were used in outdoor walking shoes. The 35 EVA group (N ¼ 39) received soft custom-made
insoles composed of EVA of 35 shore A hardness, the 55 EVA group (N ¼ 37) received custom-
made insoles composed of EVA of 55 shore hardness, and the control group (N ¼ 38) received pre-
fabricated insoles composed of a hard core with a top layer of soft 12 shore hardness microﬁber. Using
F-Scan, the in-shoe plantar pressures were measured at seven ROI (hallux, metatarsal head 1, meta-
tarsal head 2, metatarsal head 4, metatarsal head 5, lateral aspect of the mid-foot, heel) on ﬁve occasions
during the study period. The plantar-pressure variables used were PP (main outcome) and PTI. The
plantar patterns of load were explored, satisfaction and usage of the insoles were rated by the partici-
pants, and insole adjustments were recorded.
Results: A mixed model analysis estimated lower PP values in the heel regions for the 35 EVA and 55 EVA
insoles (171  13 and 161  13 kPa, respectively) than for the prefabricated insoles (234  10 kPa)
(p < 0.001). Also for some of the other six ROI indications of difference in PP or PTI could be observed.
The redistribution of peak plantar pressure for all of the insoles, was stable at the mid-foot, while the
proportion of load on the distal area changed during the study period According to the self-reported
answers (scale, 0e100), the average usage of the insoles was rated as 79 and satisfaction was rated as
85 (N ¼ 75). Thirty-two percent of the subjects had not received foot care. Fourteen adjustments to
insoles were made during the study period, and 86 pairs of insoles were exchanged due to wear, with
49% being exchanged in the 35 EVA group.A, 35 shore EVA insoles; 55 EVA, 55 shore EVA insoles; ROI, region of interest; MTH1, metatarsal head 1; MTH2,
metatarsal head 5; PP, peak pressure; PTI, pressure time integral.
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U. Hellstrand Tang et al. / Journal of Clinical & Translational Endocrinology 1 (2014) 121e132122Conclusions: Custom-made insoles used in combination with stable walking shoes gave lower pressures
at the heel region. The variation makes it difﬁcult to detect a systematic difference in plantar pressure for
the 6 ROI, if such a difference indeed exists. The levels of satisfaction and usage for all the insoles tested
were high. The insoles maintained their pressure redistribution properties over long periods, and few
adjustments were needed.
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The effective prevention of foot ulcers in the 347 million people
around the world who are diagnosed with diabetes can be achieved
with appropriate footwear [1]. Overall, 50%e86% of lower limb
amputations in patients with diabetes are preceded by foot ulcers
[2e4], which are often caused by ill-ﬁtting footwear [5,6]. The
prevalence of foot ulcers is 3%e10% [7e9], and neuropathy, pe-
ripheral vascular disease, previous ulcers or amputation, skin pa-
thology, and high plantar pressure due to foot deformities have
been identiﬁed as risk factors for the onset of foot ulcers [10e15].
The international recommendations for preventing diabetic foot
ulcers includes the prescription of appropriate footwear (insoles
and shoes), foot care, regular foot checks, and education [5]. These
preventive steps have been proven to have positive effects on pa-
tient quality of life and in reducing healthcare expenditure [16e18].
However, there is a need for long-term studies in which the pres-
sure redistribution capacities of different types of insoles are
compared [19e21]. There is also a need for a global consensus on
how to interpret the results from in-shoe pressure measurement
devices [22].
Previous research has shown that high plantar pressure can be
reduced through the use of custom-made or contoured insoles, in
combination with special footwear [23e26]. It is widely debated
among clinicians whether or not: (i) all patients with diabetes
should have custom-made insoles; and (ii) custom-made insoles
constructed from softer material are more effective in reducing
the pressures in areas where there is a high risk of an ulcer
development. Using an in-shoe pressure measurement technique,
new insights may be obtained as to plantar pressure distribution,
which will enable the formulation of recommendations related to
the optimal prescription of insoles. This paper presents the results
of a study in which patients with diabetes were given different
types of insoles and the impacts on plantar pressure were evalu-
ated. The patients were followed for 2 years with regard to dif-
ferences in the peak pressure (PP) and pressure time integral (PTI)
for different types of insoles, and additional information, e.g.,
levels of patient satisfaction with the insoles, was recorded at the
end of the study.
Several studies on this topic have been performed in recent
years. The ﬁrst randomized trial, which was conducted by Paton
and colleagues in 2012, included 119 patients with diabetes (96%
with type 1) and neuropathy [27] and compared custom-made
insoles with prefabricated insoles. The material used for both
types of insoles consisted of a 3-mm-thick EVA base (medium
density), with a top cover of 6-mm-thick Poron. Their results
showed no signiﬁcant differences in peak plantar pressure between
the different types of insoles, as measured with the F-Scan in-shoe
measurement system. However, the PTI values during walking were
lower for the custom-made insoles than for the prefabricated in the
forefoot area.
Bus et al. [28] and Owings et al. [29] measured plantar pressure
in cross-sectional studies using the Pedar shoe-pressure
measuring system. Bus et al. [28] studied 20 patients with dia-
betic neuropathy and foot deformities and showed that custom-
made CAD-CAM manufactured insoles (composed of urethanefoam over a 2-mm base with a 0.7-mm top cover) signiﬁcantly
reduced the PP and force-time integrals at the heel and ﬁrst
metatarsal head, as compared with a ﬂat insole made of open-cell
polyurethane 0.95 mm. These two types of insoles were tested in
super-depth shoes.
Owing et al. [29] established a threshold value (207 kPa) for
plantar pressure, and they recommended this value as the upper
limit that should not be exceeded if ulcer recurrence was to be
avoided. These results were obtained from a group of 49 patients
with diabetes and neuropathy who used their own shoes during the
study period. In the same study, the mean barefoot plantar peak
pressure measured with the Emed platform was 566 kPa.
The primary objective of the present study was to compare the
peak pressures (PP), maximal peak pressures (maxPP) and pressure
time integrals (PTI) for three types of commonly used insoles in a
cohort of diabetic patients with or without neuropathy. The plantar
pressure variables were studied for seven regions of interest (ROI).
The secondary objective involved exploring the redistribution
patterns of the average peak plantar pressures between the ROI, by
studying the different sources of variations in the data and
describing the insoles, adjustments, the frequencies of insole use,
and the levels of patient satisfaction.
Subjects and methods
We performed a randomized, controlled trial that comprised
patients with type 1 or type 2 diabetes who were referred to the
Department of Prosthetics and Orthotics at Sahlgrenska University
Hospital, Gothenburg, Sweden. The patients were supplied with
insoles and shoes. Data collection and pressure measurements
were performed in collaboration with the Gait Laboratory, Lund-
berg Laboratory for Orthopaedic Research, located at the same
hospital. Recruitment took place between January 2008 and
September 2009, and the patients were followed for 2 years, with
examinations at approximately 6-month intervals. In line with
regional guidelines and prevention strategies, the patients who
were referred to be supplied with insoles and shoes were those
who showed clinical signs of distal neuropathy or angiopathy, had
a history of a previous ulcers or amputation, and had foot de-
formities or foot pathologies [30]. A total of 235 participants met
the primary criteria for study eligibility, which were: 18 years of
age; diagnosis of diabetes; ability to walk unaided; ability to un-
derstand the Swedish language; no present foot ulcers and being
ﬁrst-time visitors. Patients who were included in the study were
randomly allocated to one of the following three interventions: (i)
custom-made insoles composed of ethylene vinyl acetate (EVA)
with a hardness of 35 shore A (35 EVA group; N ¼ 39); (ii) custom-
made insoles composed of EVA of 55 shore A hardness (55 EVA
group; N ¼ 37); and (iii) prefabricated insoles (control group;
N ¼ 38). The 35 shore A EVA is softer than the 55 shore EVA. A
randomization with sealed envelopes (38 in each group) was
performed prior study start prepared by the researchers at
Lundberg Laboratory for Orthopaedic Research. The allocationwas
concealed until assignment occurred and the technician was
informed of the assigned intervention. A mistake at the Depart-
ment of Prosthetics and Orthotics at study start resulted that one
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group got one less.
Custom-made insoles were fabricated using individual positive
plaster molds, based on a negative plaster cast. Casting of the foot
was performed with the patient in a prone position. The heating
and vacuum formation of the 14-mm-thick EVA material followed
the distributor’s recommendations (E603442, E603402; Össur
Nordic, Uppsala, Sweden). Patients in the control group received
prefabricated insoles (GloboTec Comfort 312750501400; Globo-
Tec, Bauerfeind, Germany) (Figure 1). One technician fabricated all
the individual insoles with a standardized metatarsal bar proximal
to metatarsal heads IIeIV. The insoles were adjusted to ﬁt into the
participant’s shoes, which were designed to be used outdoors. All
the shoes had a semi-rigid outer sole or stiff rocker bottom, a stable
heel counter, and adjustable laces or Velcro straps (Figure 1). Upon
manufacturing, the shoes were checked, to ensure that they met all
the set criteria. In addition, at each follow-up, it was conﬁrmed that
the shoes still met the criteria. Photographs were taken of the shoes
and the plantar surfaces of the feet of the subjects. All adjustments
to the insoles during the study period were registered in the cate-
gories of: higher or lower metatarsal bar; more lateral or medial
support; and more material under the heel. New insoles were
supplied when any cracks or breakdown areas in the insoles were
detected at follow-up (Figure 1). At baseline, the self-reported
status was recorded, which included the duration of diabetes,
type of diabetes, glycated hemoglobin (HbA1c) level, use of medi-
cation, use of nicotine, and ability to walk normally (yes/no).
At baseline and at each follow-up, the loss of protective sensa-
tion in the feet, deﬁned as a positive response to one of the
following tests, was assessed by measuring responses to: a) the 10-
g Semmes-Weinstein monoﬁlament; b) the C128-Hz tuning fork; c)
positioning of the big toe in extension and ﬂexion; and d) a slight
touch of a pencil [31].
At the Month-24 follow-up, all the participants ﬁlled in a
questionnaire that contained questions as to how often they had
used the insoles, how satisﬁed they were with the insoles, and
whether they had received foot care during the study period. TheFigure 1. Insoles and shoes. A) The contours of the custom-made insoles composed of et
GloboTec Comfort 312750501400 (GloboTec, Bauerfeind, Germany), with support of the me
element) that consists of a mixture of thermoplastic, polyurethane, polyester, and polycarbo
polymers with a shore density of about 12 shore A. The cover is a 2-mm layer of microﬁber, c
used in the study (Opara Deluxe men 809159, ladies 8807159; Erimed, Stockholm, Sweden)
maximum height of the toe box is 40 mm vs. 43 mm for EUR size 38/Women last vs 45/Men
presence of cracks and breakdown areas.answers to the ﬁrst two questions were recorded on a visual
analogue scale (0e100), wherein a higher value represents more
frequent use and greater satisfaction. Participants who developed
plantar ulcers discontinued the study and received appropriate
treatment. The Gothenburg regional Ethics Review Board approved
the study (diary number 299-07), and all the participants gave their
written informed consent. The complete trial protocol is available
upon request from the ﬁrst author.
Pressure measurements
After the subjects were ﬁtted with the insoles, dynamic in-shoe
pressuremeasurements weremadewith the F-Scan 6.10 (Tekscan,
Boston, MA, USA) at the Gait Laboratory. The ultra-thin pressure
sensor was trimmed to ﬁt into the participant’s shoes before the
assessment. The foot sensors had a spatial density of four pressure
sensors per cm2 and recorded the data for 400 frames in 8 s at a
sampling rate of 50 Hz. The participants walked 10 m at a self-
selected speed 6 times, and walking calibration was performed
for each individual according to the manufacturer’s recommenda-
tions and the protocol of Hsiao et al. [32]. These authors recom-
mend a calibration procedure with the sensors loaded with similar
pressure as in the trial, giving a reasonable measurement error
(1.3  5.8%). In the current study, each record was controlled for
saturation before the record was saved. The investigator looked at
the screen and conﬁrmed that the saturation level of the pressure
sensor was not reached. The sensors used had a durability that
allowed each to be used several times, and they were discarded
when signs of measurement error appeared on the screen at the
time of recording.
The F-Scan 6.62 software has predeﬁned boxes with analysis
tools for seven regions of interest (ROI), which correspond to re-
gions that are exposed to high levels of pressure duringwalking, i.e.,
the heel, lateral aspect of the mid-foot, metatarsal head 5 (MTH5),
MTH4, MTH2, MTH1, and the hallux. The predeﬁned boxes
(3  4 cm at the heel region and 2  2 cm at all the other ROI) were
manually positioned to cover the seven anatomic regions (Figure 3).hylene vinyl acetate (EVA) with a standardized metatarsal bar. B) Prefabricated insole
dial arch and a metatarsal pad in the forefoot in a material with a core (reinforcement
nate. The cushioning material is foam that belongs to the chemical family of urethane
onsisting of polyester and polyurethane. C) Photograph of a representative walking shoe
. The shoe has a semi-rigid outer sole, a stable heel counter, and adjustable lacing. The
last. D) An example of a custom-made insole that is ready to be exchanged due to the
Figure 2. Flow chart for the participants in the study and the reasons for study drop-outs. The “measurement time point” reﬂects the time interval and is reported as a range
(minimum to maximum). The numbers of participants are presented in parentheses. Reasons for dropping out are explained as follows: *participant drop-out for personal reasons;
yother disease made participation impossible; z participant wanted to change material of the insoles or the participant was prescribed another insole material.
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Figure 3. Peak pressure in seven regions of interests A-G. For each region of interest, the peak pressures for three types of insoles are presented as a box plot. Gray boxes represent
the 35 EVA insoles, black boxes the 55 EVA insoles, and white boxes the prefabricated insoles. The outliers (circles) represent high pressure levels and give evidence as to the
signiﬁcant inter-individual variation. For the heels, the pressures in the prefabricated insoles are higher than those in the custom-made 35 EVA and 55 EVA insoles at each follow-up
(p < 0.001) H. Schematic of the seven regions of interests displayed in the F-Scan.
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(baseline and four follow-ups at 6-month intervals). However, in
reality, this interval varied between the patients, so the term
“measurement time point” was used to reﬂect the time interval
(Figure 2).
At each time-point, six walking trials, consisting of four to eight
steps, were performed. One of the six trials was randomly selected
for analysis. The ﬁrst and last steps were excluded in the calcu-
lation of the average peak pressure for the trial. Three different
variables describing different aspects of plantar pressure distri-
bution were analyzed [1]: peak pressure (PP) [2]; maximum peak
pressure (maxPP); and [3] pressure time integral (PTI). Peak
pressure was deﬁned as the maximum peak plantar pressure
sensed for each cm2 in the positioned boxes per footstep, averaged
over ﬁve to seven footsteps. The maxPP is the highest pressure
sensed within each of the seven ROI over the same number
of footsteps. The calculation PTI followed the equation:
PTI ¼ P1  T1 þ P2  T2 þ . PN  TN, where P1 is the total
pressure present in the ﬁrst frame of the stance, T1 is the duration
(time) of the ﬁrst frame of the stance, PN is the total pressure
present in the last frame of the stance, and TN is the duration of
the ﬁnal frame of the stance (from F-Scan User Manual 6.62, Rev
H). Stance number 3 was selected for the analysis of PTI, as
measured in kiloPascals  second.Participants
In total, 86 (75%) of the participants assessed at baseline
completed the four follow-ups. At baseline, 31 (27%) were diag-
nosed with type 1 diabetes and 83 (73%) were diagnosed with type
2 diabetes, 62 (54%) were male and 52 (46%) were female, and the
mean HbA1c (N ¼ 106) was 6.4%  1.8 (46 mmol/mol).
At baseline, 43 (38%) of the participants had a loss of protective
sensation, deﬁned as a positive response to any of following tests:
monoﬁlament (18%); vibration (37%); proprioception (11%); or su-
perﬁcial (6%). Smoking was reported by 18% of the participants, and
6% used tobacco snuff. Overall, 65% of the participants were being
treated for high blood pressure or heart disease. More than 70% of
the participants in each group reported normal walking ability (79%
in the 35 EVA insoles group; 76% in the 55 EVA insoles group; and
71% in the prefabricated insoles group). Most of the participants
(97%; N¼ 111) used walking shoes with a semi-rigid outer sole. One
participant in each group used shoes with a stiff rocker bottom sole.
The baseline characteristics of the participants are presented in
Tables 1A and B.
While 570 pressure measurements were planned (ﬁve separate
occasions for the 114 participants), 131 (23%) were lost due to pa-
tient drop-out (N ¼ 90), patients not attending follow-ups (N ¼ 38),
and technical errors (N¼ 3). In the 35 EVA group, 52 measurements
(27%) were missing, whereas in the 55 EVA group, 43 (23%) were
missing and 36 (20%) were missing in the prefabricated group.
Two participants developed foot ulcers during the study and
were excluded. The sites of these ulcers were the plantar aspect of
MTH3 and digit three. Both of these participants weremenwho had
been assigned to the 55 EVA group (Figure 2).Table 1A
Baseline characteristics of the patients. Values shown for continuous variables are mean
N Age (years) Female (%) Diabetes type 1 (%) Duration o
35 EVA 39 58 (16.8) 44 39 13 (13)
55 EVA 37 57 (15) 41 16 9 (7)
Prefab 38 59 (15) 53 29 15 (12)
Total 114 58 (15) 46 28 12 (11)The patients who were not included in the study due to ineli-
gibility or lack of interest (N ¼ 121, 56% male, 44% female) were
aged 60  14 years (Figure 2).
The sample size (N ¼ 114) was based on a pilot study that
compared the differences in forefoot PP, measuredwith the F-Scan
in-shoe pressure measurement device, between custom-made in-
soles of the 35 EVA and 55 EVA types [33]. The calculation of sample
size was based on an effect size in PP of 30 kPa, a ¼ 0.05, power of
80%, and a dropout rate of 15%.Statistical methods
Several statistical analyzes of the data, using both explorative
methods, such as graphs, andmore formal approaches, such as tests
and modeling, were performed. To avoid additional complications
arising from the dependence upon measurements for the left and
right foot, only the data for the right foot were used in all the an-
alyses. An exploratory overview of the pressure data was made for
each type of insole using the raw data for PP, maxPP, and PTI and the
results are presented as mean (SD) for the seven ROI in Table 2. The
raw date included the values obtained from all the follow-ups for
each participant. To illustrate the distribution of PP values, we also
created boxplots for the three types of insoles for each of individual
time-points from baseline to the fourth follow-up (Figure 3). The
proportions of load for the different ROI are shown in separate
ﬁgures for each type of insole (Figure 4). The proportion of and
change in load, during the study, were calculated for each ROI in
relation to the sum of the peak pressures for all seven ROI. In a ﬁnal
exploratory analysis, a mean value for each type of insole was
calculated.
After performing the exploratory part, we proceeded to
compare the PP and PTI values for the 35 EVA and 55 EVAwith the
corresponding values for the prefabricated insoles using a mixed
model. This model explicitly takes into account the dependence
structure of the data (Table 3). The model had only one random
effect, namely an intercept, with patients considered as the
grouping factor. The “intercept” factor denotes a baseline, i.e., the
estimated mean pressure for new prefabricated insoles. It
included two main effects: type of insoles and time since the last
change of insoles. This essentially means that we assume that
there is a certain effect that different types of insoles have on
pressure, although this effect may change in a linear fashion as the
insoles get older and wear out. The resulting estimates of the main
effects, as well as the corresponding standard deviations are
presented in Table 3. The “Diff. 35 EVA” and “Diff. 55 EVA” pa-
rameters give the estimated difference in pressure between new
custom-made and new prefabricated insoles. Finally, the term
“Age of insoles” factor accommodates the possibility that the ef-
fect of insoles on plantar pressure may change as the insoles
become worn-out.
Several sub-analyzes of the datawere also made. In the ﬁrst sub-
analysis, the differences in total loaded plantar surface area (cm2)
between the different insoles were evaluated. This evaluation was
performed ﬁrst using ANOVA, and then proceeding to pair-wise
comparisons with t-tests. To account for multiplicity, Dunnett’s(SD)
f diabetes (years) BMI (kg/m2) HbA1c (mol/mmol) Neuropathy (%, N)
28 (5) 6.3 (0.9) 38.5 (15)
28 (4) 6.5 (2.6) 35.1 (13)
28 (5) 6.4 (1.7) 37.5 (12)
28 (5) 6.4 (1.8) 37.7 (43)
Table 1B
Baseline peak pressures, maximal peak pressures, pressure time integrals and areas of seven regions of interests in the feet of the subjects
Patients (N) Hallux Metatarsal head 1 Metatarsal head 2 Metatarsal head 4 Metatarsal head 5 Mid-foot Heel Area (cm2)
Peak pressure in kPa
35 EVA 39 200 (99) 195 (95) 255 (84) 168 (70) 141 (74) 128 (69) 175 (58) 182 (22)
55 EVA 37 232 (130) 211 (103) 294 (83) 155 (69) 136 (102) 109 (53) 159 (57) 177 (22)
Prefab 38 206 (122) 237 (145) 292 (110) 180 (75) 151 (89) 82 (49) 237 (94) 170 (19)
Total 114 212 (118) 214 (112) 280 (94) 168 (72) 143 (88) 107 (60) 191 (79) 176 (21)
Maximal peak pressure in kPa
35 EVA 39 235 (109) 255 (127) 281 (95) 197 (76) 187 (92) 176 (92) 191 (61) 182 (22)
55 EVA 37 284 (142) 269 (142) 322 (93) 193 (84) 179 (120) 145 (66) 176 (62) 177 (22)
Prefab 38 249 (153) 301 (172) 327 (127) 213 (83) 203 (122) 120 (62) 261 (98) 170 (19)
Total 114 256 (136) 275 (148) 310 (107) 201 (81) 190 (111) 147 (78) 209 (84) 176 (21)
Pressure time integral in kPa  sec
35 EVA 39 34 (19) 39 (22) 55 (24) 46 (22) 38 (19) 43 (24) 37 (14) 180 (22)
55 EVA 37 36 (23) 40 (24) 61 (22) 37 (16) 33 (23) 37 (22) 32 (15) 174 (22)
Prefab 38 30 (14) 46 (26) 57 (21) 50 (25) 44 (25) 31 (24) 53 (28) 167 (22)
Total 114 33 (19) 42 (24) 58 (22) 44 (22) 38 (23) 37 (24) 41 (22) 174 (22)
Values shown for continuous variables are mean (SD).
BMI, body mass index; 35 EVA, 35 shore ethylene vinyl acetate-containing custom-made insoles; 55 EVA, 55 shore ethylene vinyl acetate-containing custom-made insoles;
Prefab, prefabricated insoles.
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different time-points for the same patient were expected to be
dependent, this analysis was performed not on the raw data, but
rather on the average of the loaded area (averaging for each patient
over time). Thus, an additional response variable, termed
“AVERAGE area,” was introduced.
In the second sub-analysis, differences in PP values for the
participants with and without neuropathy were evaluated with a
t-test. Following the reasoning outlined above, the response
variable analyzed was “AVERAGE peak pressure” (averaging the
PP for each patient over time). The calculation was done for all
seven ROI.
The third sub-analysis was a further examination of the distri-
bution of the data, made by examining measurement variations in
ﬁve randomly selected participants. For these ﬁve participants, the
pressure measurements for all 30 separate walks were available.
Thus, the within-subject variation, “measurement error,” for eachTable 2
Results of plantar pressure measurements recorderd in patients with diabetes including
Region of interest 35 shore EVA insoles (N ¼ 143) 55
Mean (SD) 2SD Me
Peak pressure in kPa
Hallux 206 (118) 187e226 259
MTH1 189 (85) 175e203 217
MTH2 251 (118) 231e270 259
MTH4 197 (89) 182e212 193
MTH5 144 (83) 130e157 127
Mid-foot 98 (47) 91e106 95
Heel 178 (64) 168e189 171
Maximum peak pressure in kPa
Hallux 257 (144) 233e281 314
MTH1 244 (109) 227e262 270
MTH2 288 (136) 265e310 291
MTH4 234 (103) 217e251 230
MTH5 190 (103) 173e207 171
Mid-foot 137 (62) 127e148 135
Heel 202 (76) 189e215 193
Pressure time integral in kPa  sec
Hallux 36 (20) 33e40 39
MTH1 40 (20) 37e43 42
MTH2 54 (23) 50e58 55
MTH4 49 (21) 46e53 46
MTH5 39 (21) 35e42 36
Mid-foot 32 (18) 29e35 33
Heel 41 (19) 38e44 35
The three variables of pressure, measured at time points 0e4, are grouped for each type
metatarsal head 1; MTH2, metatarsal head 2; MTH4, metatarsal head 4; MTH5, metatarROI at time-points 0e4 was compared with the between-subject
variation, “population diversity.”
Finally, the participants with values of peak pressure that
exceeded 500 kPa were examined separately.
The Microsoft Excel 2010, SPSS version 19, and R software
packages were used for the statistical calculations.
Results
The results of the exploratory analysis for PP, maxPP, and PTI at
baseline for the three types of insoles are presented in Tables 1A
and B. The graphical presentation (Figure 3) shows that all three
insoles produced a median pressure of approximately 200 kPa
throughout the study.
The distributions of the proportion of peak pressure during the
study for each ROI and for each type of insole are presented in the
Figure 4. The highest peak pressures were at MTH2 and the hallux,those with and without neuropathy
shore EVA insoles (N ¼ 142) prefabricated insoles (N ¼ 154)
an (SD) 2SD Mean (SD) 2SD
(114) 240-278 250 (137) 229-272
(95) 201e232 238 (130) 217e259
(95) 242e275 283 (119) 264e302
(86) 179e207 202 (85) 189e216
(65) 116e128 163 (88) 149e177
(44) 88e102 99 (69) 88e110
(57) 162e181 242 (88) 228e256
(133) 292e336 316 (171) 288e343
(123) 249e290 303 (161) 277e328
(103) 274e309 327 (139) 304e349
(96) 214e246 246 (103) 230e263
(81) 158e185 225 (120) 206e244
(62) 125e145 145 (95) 130e160
(67) 181e204 276 (102) 260e293
(21) 36e43 37 (21) 33e40
(21) 38e45 49 (28) 45e54
(23) 51e59 59 (29) 54e63
(19) 43e49 48 (19) 45e51
(20) 33e39 45 (26) 41e49
(19) 30e36 29 (18) 26e32
(13) 33e37 54 (23) 50e58
of insole and presented as the means (SD) for the seven regions of interest. MTH1,
sal head 5. N, number of valid measurements.
Figure 4. Proportion of peak pressure during the study period Patients with diabetes
who were at risk of developing foot ulcers (N ¼ 114) took part in an intervention with
three types of insole: A, 35 shore EVA insoles; B, 55 shore EVA insoles; C, prefabricated
insoles. The distributions and changes over time of the plantar peak pressures are
presented as the proportion of load for each region of interests. The proportional loads
are highest at metatarsal head 2 and the hallux. MTH1, metatarsal head 1; MTH2,
metatarsal head 2; MTH4, metatarsal head 4; MTH5, metatarsal head 5.
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types. The redistribution properties over the PP over the 2 years
were stable at the mid-foot, while the proportion of load on the
distal area changed during the study period. The overall peak
pressures for the custom-made 35 EVA and 55 EVA insoles were
lower than those for the prefabricated insoles (35 EVA, 180 kPa (15%
lower); 55 EVA, 189 kPa (10% lower); prefabricated, 211 kPa), as we
ignored the differences in the seven ROI.From the mixed models analysis (Table 3), a clear difference is
evident only for the heel region between the two custom-made
insoles and the prefabricated insoles. The estimated difference
in PP between the EVA 35 insoles and the prefabricated insoles
was 63 kPa, and the estimated difference between the 55 EVA
insoles and the prefabricated insoles was 72 kPa (p < 0.001 for
both comparisons). The estimated difference in PTI between the
35 EVA insoles and the prefabricated insoles was 14 kPa  sec,
and the estimated difference between the 55 EVA insoles and the
prefabricated insoles was 20 kPa  sec (p < 0.001). For such small
p-values, the statistical signiﬁcance would remain even if a
multiplicity correction procedure (e.g. Bonferroni) would be
performed.
The mixed model analysis also indicated possible differences in
PP values between the prefabricated insoles and the EVA 35 insoles
for MTH1 (p ¼ 0.046) and MTH2 (p ¼ 0.041), and a possible dif-
ference between the prefabricated insoles and EVA 55 insoles for
MTH5 (p ¼ 0.02). However, it should be borne in mind that these
p-values are calculated without taking into account the issue of
multiple hypotheses testing, and thus, although they indicate a
difference, this cannot be seen as a conﬁrmation of its existence.
Several of the mixed effects models (PP and PTI for the heel
region, PTI for MTH4 and MTH5) also detected a possible effect of
the “Age of insoles.” For all of these, the estimate of the effect was
positive, supporting the intuitive belief that the pressures at some
ROI should increase as the soles become older.
In the ﬁrst sub-analysis of the total loaded plantar surface using
ANOVA, the null hypothesis of no difference between the insoles
could be rejected with a p-value of 0.028. The subsequent Dun-
nett’s test gave p < 0.015 with an estimated difference of 12 cm2
when comparing EVA 35 insoles with the prefabricated insoles,
and p ¼ 0.174 (estimated difference of 8 cm2) when comparing
EVA 55 insoles with the prefabricated insoles. Therefore, we
conclude that the total loaded area differs between the EVA 35 and
prefabricated insoles. The second sub-analysis showed no statis-
tically signiﬁcant differences between participants with and
without neuropathy. The AVERAGE peak pressure was lower at the
hallux region and higher at the heel for those participants with
neuropathy (for the hallux, 215 kPa vs. 250 kPa, p < 0.063; for the
heel, 202 kPa vs. 191 kPa, p ¼ 0.399; values for ‘with neuropathy’
versus ‘without neuropathy’).
The third sub-analysis of the variation (within-subject variation
divided by between-subject variation, which we refer to as the
“relative variance”) in PP values for the ﬁve participants’ mea-
surements (seven ROI at ﬁve time-points) showed variance of<20%
in 74% (n ¼ 26) of the measurements. Relative variance levels of
>20% and <30% appeared in 20% (n ¼ 7) and relative variance of
>30% appeared in 6% (n ¼ 2) of the measurements.
Finally, the subjects with extremely high PP levels under the sole
of the foot (>500 kPa) were examined separately. Such high pres-
sures were observed in six participants. By analyzing images of the
plantar surface in these cases, calluses, thin fat pads, and foot de-
formities were identiﬁed and found to correspond to the areas with
PP values >500 kPa.
Patient compliance with the insoles was reported, with a mean
score of 79 on the 0e100 analogue scale (N¼ 75) at the ﬁnal follow-
up (for the 35 EVA, 55 EVA, and prefabricated insoles groups: 73, 81,
and 84, respectively). The satisfaction level was 85 (for the 35 EVA,
55 EVA, and prefabricated insoles groups: 86, 87, and 81, respec-
tively). Forty-nine (66%) of the participants reported having had
access to foot care.
In total, 86 pairs of insoles were exchanged due to wear (49% of
the replacements occurred in the 35 EVA group, 20% in 55 EVA
group, and 31% in the control group). Forty-three percent (N ¼ 49)
of the participants used the original pair of assigned insoles
Table 3
Summary of the model with random intercepts. The response variables are plantar peak pressure and pressure time integral and the model includes twomain effects: the type
of insoles and ‘Age of insoles’ (days)
Peak plantar pressure (kPa) Pressure time integral (kPa  sec)
Value Std. Err. DF t-value p-value Value Std. Err. DF t-value p-value
Hallux
(Intercept) 248.84 16.66 323 14.94 0 35.91 2.67 323 13.43 0.00
Diff. 35 EVA 39.40 22.40 111 1.76 0.08 0.25 3.55 111 0.07 0.94
Diff. 55 EVA 9.92 22.68 111 0.44 0.66 2.75 3.59 111 0.77 0.44
Age of insoles 0.00 0.02 323 0.09 0.93 0.00 0.00 323 1.01 0.31
Metatarsal head 1
(Intercept) 241.52 14.70 323 16.43 0.00 50.51 3.22 323 15.68 0.00
Diff. 35 EVA 40.32 19.96 111 2.02 0.05* 7.55 4.37 111 1.73 0.09
Diff. 55 EVA 15.45 20.21 111 0.76 0.45 6.76 4.42 111 1.53 0.13
Age of insoles 0.02 0.01 323 1.82 0.07 0.01 0.00 323 1.78 0.08
Metatarsal head 2
(Intercept) 291.11 15.05 323 19.34 0.00 58.57 3.29 323 17.82 0.00
Diff. 35 EVA 41.92 20.23 111 2.07 0.04* 5.63 4.39 111 1.28 0.20
Diff. 55 EVA 29.26 20.48 111 1.43 0.16 5.16 4.44 111 1.16 0.25
Age of insoles 0.01 0.02 323 0.56 0.58 0.00 0.00 323 1.06 0.29
Metatarsal head 4
(Intercept) 202.49 11.29 323 17.94 0.00 46.54 2.63 323 17.70 0.00
Diff. 35 EVA 10.28 15.17 111 0.68 0.50 0.09 3.53 111 0.02 0.98
Diff. 55 EVA 10.69 15.36 111 0.70 0.49 2.51 3.57 111 0.70 0.48
Age of insoles 0.00 0.01 323 0.26 0.80 0.01 0.00 323 2.61 0.01*
Metatarsal head 5
(Intercept) 156.00 10.97 323 14.22 0.00 41.95 3.01 323 13.95 0.00
Diff. 35 EVA 21.33 14.93 111 1.43 0.16 6.22 4.07 111 1.53 0.13
Diff. 55 EVA 35.07 15.12 111 2.32 0.02* 9.14 4.12 111 2.22 0.03*
Age of insoles 0.02 0.01 323 1.91 0.06 0.01 0.00 323 3.06 0.00**
Mid-foot
(Intercept) 96.09 7.31 323 13.14 0.00 28.68 2.42 323 11.85 0.00
Diff. 35 EVA 0.55 9.87 111 0.06 0.96 3.06 3.25 111 0.94 0.35
Diff. 55 EVA 5.63 9.99 111 0.56 0.57 2.52 3.29 111 0.77 0.45
Age of insoles 0.01 0.01 323 1.27 0.20 0.00 0.00 323 0.70 0.48
Heel
(Intercept) 234.12 9.52 323 24.60 0.00 52.15 2.59 323 20.14 0.00
Diff. 35 EVA 63.59 12.80 111 4.97 0.00*** 13.98 3.52 111 3.97 0.00***
Diff. 55 EVA 72.56 12.96 111 5.60 0.00*** 20.10 3.56 111 5.64 0.00***
Age of insoles 0.02 0.01 323 2.50 0.01* 0.01 0.00 323 3.61 0.00***
Intercept, the estimated mean pressure for new prefabricated insoles.
Diff. 35 EVA, the differences between the custom-made 35 EVA insoles and the prefabricated insoles. Diff. 55 EVA, the differences between the custom-made 55 EVA insoles and
the prefabricated insoles. Std. Err, standard error; DF, degree of freedom.
*p < 0.05, **p < 0.005, ***p < 0.001.
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group, calculated as the mean number of days (SD), was 260 (252)
days for the 35 EVA group, 327 (284) for the 55 EVA group, and 318
(278) days for the prefabricated insoles group. In all, 14 adjustments
to insoles were made during the study. Ten adjustments weremade
in the 55 EVA group and two in each of the other groups. The ad-
justments made to insoles in the 55 EVA group were: lowering of
the metatarsal bar (n ¼ 5); addition of material beneath the insoles
(n ¼ 2); ofﬂoading a bony prominence at digit three (n ¼ 1); and
unspeciﬁed (n ¼ 2). One insole had both an adjustment of a lower
metatarsal bar and added lateral support. The adjustments made to
insoles in the 35 EVA group involved the addition of material under
the heel (n ¼ 2). The adjustments made to the prefabricated insoles
were: the addition material under the heel (n ¼ 1); and unspeciﬁed
(n ¼ 1).
Discussion
The most important ﬁnding of the present study is the signiﬁ-
cantly lower pressure at the heel observed in the comparisons of
the custom-made insoles with the prefabricated insoles. Both the
PP and PTI analyzes of the heel conﬁrmed this ﬁnding. Aging of the
insoles also had an effect on the PP and PTI at this ROI.
The pressure redistribution capacities of custom-made insoles
in the heel region assessed in the present study are inaccordance with the previously described results of Bus et al.
[28]. Pressure reduction in the heel region is probably due to the
casting procedure, which entails tight molding that follows the
contour of the heel. A three-dimensional view of a custom-made
insole (Figure 1) shows a narrow heel width together with high
edges, which retain the heel pad under the bony prominences of
the calcaneus, thereby providing cushioning. Thus adjusting the
prefabricated insoles with higher edges that are positioned tight
to the heel can be assumed to improve the pressure reduction
properties.
The overall peak pressures on the foot soles of the patients
who wore custom-made insoles in our study were 180 kPa and
189 kPa. These pressures are comparable to the overall peak
pressures reported by Ledoux et al. [34], who studied patients
with diabetes with or without foot ulcers. They also used the
F-Scan in-shoe pressure measurement system and reported
overall mean peak pressures of 194 kPa for patients without ul-
cers (N ¼ 274) and 219 kPa for patients with foot ulcers (N ¼ 47).
In that study, 81% of the patients the ulcerated group had neu-
ropathy, whereas 48% of the non-ulcer group had neuropathy.
The patients with foot ulcers in the study of Ledoux et al. [34] had
an overall peak pressure that was higher than the patients in the
current study (none of whom had foot ulcers) who were provided
with prefabricated insoles (211 kPa). However, the results of
the overall peak pressure measurements might not be fully
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than current study.
The clinically relevant reference value to avoid diabetic foot ul-
cers recurrence has been variously reported as 207 kPa (measured
using the Pedar system) and 291 kPa (measured with the Pliance
system) [29]. These values are similar to the peak pressures ob-
tained for all three insoles in the present study (Table 2). However,
comparisons of threshold values should be interpreted with care,
due to differences between ROI and differences in applied tech-
nologies (e.g., spatial resolution, pressure range, sampling calibra-
tion procedure, and raw data pre-processing) between the Pedar,
Pliance, and F-Scan systems. The implication is that all three
types of insoles possibly might reduce the pressure at the heel to a
degree that prevents stress on the soft tissue. The issue as to
whether or not differences in pressure distribution properties exist
for the remaining six ROI analyzed here is not resolved in the
present study.
Based on the results of the present study, we recommend that
patients with diabetes should be given custom-made insoles when
reduction of the peak pressure in the heel region is the primary
goal. The current results can be generalized and are clinically
applicable to patients with diabetes with or without neuropathy
and without ulcers. It is assumed that walking shoes are used
together with the insoles.
The second aim of the study was to explore the patterns of
plantar pressure redistribution in the patients who wore the shoes
with the different insoles. The proportion of the load shown in
Figure 3 indicates that small changes occur over time in the seven
ROI for all of the different insoles. The load on the forefoot is larger
than that on the mid-foot. The main differences are in the heel
region, with higher relative pressures for the prefabricated insoles
than for the custom-made insoles. Differences between the insoles
can be seen in the hallux region and the metatarsal heads. The
reasons to the variation of pressure over time in these distal regions
are not fully understood.
Three different pressure measurement outcomes were used in
the present study, due to the lack of international consensus, to
evaluate the different aspects of plantar pressure distribution. The
PP variable and PTI are commonly applied in studies that use
F-Scan in-shoe pressure-measuring devices [27,34]. The maxPP
parameter was added for descriptive purposes (Tables 1A and B and
Table 2), although is omitted in the subsequent analyzes. The sub-
analyzes of total loaded plantar area are presented for the reader
to evaluate further the differences in contact between the foot and
insoles for the different types of insoles.
Twenty-eight (25%) of the participants were lost to the ﬁnal
follow-up. They left the study due to personal reasons (N ¼ 15),
disease (N ¼ 6), change of insoles (N ¼ 3), death (N ¼ 2), and the
development of foot ulcers (N ¼ 2). The missing pressure mea-
surements (n ¼ 90) are mainly due to drop-outs (69%). The high
dropout rates (25%e50%) observed for patients with diabetes at risk
of developing ulcers must be considered when designing future
trials. Bus et al. [35], who followed patients with diabetes and a
healed foot ulcers over 18 months, reported a drop-out rate of 47%.
The annual incidence of foot ulcers in the present study (0.9%) is
lowcomparedwith previously those in published population-based
studies from the UK (2%), and USA (3%) [36,37]. To evaluate the
outcome of the yearly incidence of foot ulcers, a higher number of
participants needs to be included in future studies.
In total, 14 adjustments to the insoles were made during the
study. The 55 EVA insoles accounted for most (71%) of these ad-
justments. Overall, 43% of the participants did not change their
shoe insoles during the entire study period. This result includes
the participants who left the study before the last follow-up. It is
noteworthy that the prefabricated and 35 EVA insoles had to beexchanged more frequently due to material fatigue. Surprisingly,
the prefabricated insole had a longer life-span than the custom-
made insoles. The life-span data show a large standard devia-
tion, which is attributable to the extensive inter-subject vari-
ability; some participants exchanged their insoles frequently,
while others used the originally assigned insoles for the entire
duration of the study. The patient-reported outcomes reveal
extensive use of the insoles and a high level of satisfaction among
the participants, which are of importance for the prevention of
diabetic foot ulcers [38,39]. At the point in time when the present
study initiated objective estimates of compliance were not avail-
able, therefore we used a visual analogue scale. To our knowledge,
the ﬁrst report of an objective instrument for adherence to foot-
wear was presented in Year 2012 [40].
Prevention strategies to avoid foot ulcers recommend that foot
care be included. In the present study, one-third of the patients had
not received any foot care. Based on our result it is advisable to
combine insole use with routine foot care.
Limitations
The study showed a high level of variation for the PP, maxPP, and
PTI values (Tables 1A and B and Table 2). These variations are similar
to those reported in other studies [23e25,29], although the reasons
for the variations are not fully understood. The current analysis of
ﬁve randomly selected participants conﬁrms the large variations,
even though the measurements were recorded under stable and
similar conditions for all the participants. All the participants
walked on a level ﬂoor and used the same type of shoe during the
assessments. The variability observed in the present study may be
related to the complicated, dynamic nature of walking and the
physiologic factors associated with diabetes [41,42]. The variations
in the pressure values can be attributed to a combination of the
participant’s adjustment and co-ordination in order to maintain
balance, some technical error, and a wrinkled sock or sensor. The
sensors used at each time-point were not assigned to a speciﬁc
individual, possibly adding to the within-subject variation. The
sensor had the following technical properties: linearity, 3%, ac-
cording to the end-point linearity of the transducer; hysteresis,
<4.5% of full-scale output; and repeatability, 3.5%, giving
reasonable accuracy. To achieve a high level of accuracy, equili-
bration is recommended before calibration is performed [43].
However, at the time that this study started, this was not a rec-
ommended procedure, and walking calibration was used to ensure
appropriate accuracy.
In the sub-analysis of the six participants, who had PP values
>500 kPa, some explanations for the large variation were found.
During analysis of the photographs of the plantar surfaces of the
feet of these participants, we noted the presence of atrophied fat
pads, foot deformities, and calluses. Correlations between foot de-
formities, a thin fat pad, and gait deviation have previously been
detected, although this remains a topic for further investigation
[15,44]. Only one of the ﬁve walking trials performed at each
follow-up was analyzed due to the time-consuming manual pro-
cedure required to translate the data into numerical form. The
availability of appropriate software, including the possibility to run
the analysis automatically, would allow processing of all the data on
plantar pressures and would decrease the variation. This would
facilitate the detection of differences in the pressure redistribution
properties in regions other than the heel. A limitation of the present
study is that in-shoe pressure measurements were not performed
when the patients walked with their assigned shoes without any
insoles. Finally, barefoot measurements were not included in the
present study. This was because the participants were recom-
mended not to walk barefoot, as this might entail a risk for trauma.
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evaluation of the effectiveness of the intervention.
Measurement errors
Attempts to capture dynamic walking and the properties of
three-dimensional insoles in a longitudinal study have inherent
limitations, which might lead to measurement errors. First, the in-
shoe pressure measurement only registers two-dimensional forces
between the foot sole and the shaped insoles; shear forces are not
recorded [45]. Second, equilibration and calibration procedures
might affect the accuracy of subsequent measurements and is a
topic for further investigation. The intra- or inter-subject variations
in gait velocity, as well as the types of hosiery used were not strictly
controlled during the study.
Conclusions
We conclude that for patients with diabetes who are at risk for
foot ulcers, custom-made insoles used in combination with stable
walking shoes result in lower pressure levels at the heel region (one
of the seven regions of interest investigated), as compared with
walking shoes with the type of prefabricated insoles that were
tested in the present study. The observed variability of the mea-
surements makes it difﬁcult to deﬁne systematic differences in
plantar pressure for the other six regions of interest of the foot. The
levels of self-reported satisfaction and usage of the insoles were
high, and the insoles retained their pressure redistribution prop-
erties over a long time, so few adjustments were needed.
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